市場調査レポート

神経刺激療法の世界市場

Neurostimulation

発行 Global Industry Analysts, Inc. 商品コード 136191
出版日 ページ情報 英文 220 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
神経刺激療法の世界市場 Neurostimulation
出版日: 2015年11月01日 ページ情報: 英文 220 Pages
概要

レポートでは、世界の神経刺激療法市場について調査し、市場の概要と2020年までの予測、地域別動向、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 市場概要
    • 概要
    • 主な神経刺激治療および適応症
    • 今後の見通し
    • 先進国:従来の収益貢献地域
    • 途上国が将来の市場成長を牽引
    • 脊椎刺激:急成長市場
  • 競合シナリオ
    • 複数の企業が市場を独占
    • 世界の市場:製品セグメント別
    • FDA認可済み製品
    • 開発中の製品
    • 適応別神経刺激研究企業
    • PNS分野における競合
  • 成長牽引因子、動向、課題
  • マクロ的成長促進因子
    • 世界的人口増加が大きな成長の機会に
    • 高齢化
    • 人口統計
    • 寿命の延びが市場成長を牽引
    • 可処分所得の増加が市場成長を牽引
    • 医療費改善が成長を促進
  • 神経刺激療法市場における技術進歩
  • 標的とする適応症
  • 製品概要
  • 神経刺激装置の認可
  • 製品革新/導入
  • 近年の業界活動
  • 主要企業
    • Aleva Neurotherapeutics SA
    • BioControl Medical
    • Bioness Inc.
    • Boston Scientific Corp.
    • EnteroMedics Inc.
    • LivaNova PLC
    • Medtronic, Inc.
    • NeuroPace, Inc.
    • NeuroSigma, Inc.
    • Nevro Corp.
    • SPR Therapeutics, LLC
    • St. Jude Medical, Inc.
    • Synapse Biomedical, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の諸国

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-1227

This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES). The United States is analyzed both in terms of value (US$) and volume (units) sales. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as -

Aleva Neurotherapeutics SA
BioControl Medical
Bioness Inc.
Boston Scientific Corp.
EnteroMedics Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Spinal Cord Stimulation (SCS)
    • Deep Brain Stimulation (DBS)
    • Sacral Nerve Stimulation (SNS)
    • Vagus Nerve Stimulation (VNS)
    • Gastric Electric Stimulation (GES)

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Market Primer
  • Major Neurostimulation Therapies and Indications At A Glance
  • Outlook
    • Table 1: Global Neurostimulation Market - Product Segments Ranked by CAGR (Value Sales) for 2014-2020: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart)
  • Developed Markets: Traditional Revenue Contributors
  • Developing Countries Turbo Charge Future Market Growth
    • Table 2: Global Neurostimulation Market - Geographic Regions Ranked by CAGR (Value Sales) for 2014-2020: Asia-Pacific, Latin America, Rest of World, Europe, Japan, US, and Canada (includes corresponding Graph/Chart)
  • Spinal Cord Stimulation (SCS): A Rapidly Evolving Market

2. COMPETITIVE SCENARIO

  • Few Players Dominate Neurostimulation Market
  • Worldwide Neurostimulation Market: Leading Players by Product Segment
    • Table 3: Leading Players in the Global Neurostimulation Devices Market (2014): Percentage Share Breakdown of Value Sales for Medtronic, Boston Scientific, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart)
  • FDA-Approved Products of Leading Players in the Neurostimulation Market
  • Select Neuromodulation Products under Development
  • Companies Researching Neurostimulator Applications by Indication
  • Competition in the PNS Space

3. GROWTH DRIVERS, TRENDS, & ISSUES

  • New Indications Expand Opportunities for Growth
  • Growing Awareness and Acceptance Among Physicians
  • Neuropathic Pain: A Highly Underserved Market
  • Peripheral Nerve Stimulation (PNS): A Potential Area for Pain Management Devices
  • Occipital Nerve Stimulation (ONS): An Untapped Market with Potential
  • Steering Brain Stimulation - An Emerging Concept in DBS
  • Novel Applications Bode Tremendous Prospects
  • Obesity Control to Spur Market Growth in Future
    • Table 4: Obese and Overweight, and Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart)
    • Table 5: Global Obesity Population by Region/Country: 2013 (includes corresponding Graph/Chart)
  • Powering Neurostimulation Devices- The Key to Success
  • Closed-Loop Functionality Gaining Favor over Open-Loop in Neurostimulation
  • Device Programmability Gains Precedence in Device Choice
  • Novel Electrode Configurations Aid in Localization and Side Effect Reduction
  • Advances in Programming Promise Ease of Treatment
  • Vagus Nerve Stimulation for Treating Obesity
  • Trigeminal Nerve Stimulation - A Promising Area
  • Nanotechnology - The Future of DBS Electrodes
  • Synergy with Pharma & Biotech Companies Creates New Avenues
  • Third-Party Reimbursement - A Vital Role to Play
  • Outsourcing - A Growing Phenomenon
  • Chip Makers Struggle to Meet Quality Demand
  • Product Complexity: A Cause of Concern
  • Concerns Remain Afloat - Affecting Adoption
  • Hardware-related Infections - A Major Concern
  • Battery Life - A Bone of Contention for Neurostimulation
  • Neurostimulation Market Marked by High Entry Barriers

4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY

  • Ballooning Global Population Offers Significant Growth Opportunities
    • Table 6: Top 25 Countries Worldwide in Terms of Population (2010 & 2013) (includes corresponding Graph/Chart)
  • Aging Global Population: A Major Growth Propeller
  • Demographic Statistics of Aging Populace: Unfurling the Market Potential
    • Table 7: Aging (65+) Demographics as a Percentage of Total Population for Major Countries: 2000, 2011, and 2020 (includes corresponding Graph/Chart)
    • Table 8: Global Aging Population (in Thousands) by Age Group: 1975, 2000, 2025, and 2050 (includes corresponding Graph/Chart)
    • Table 9: Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart)
  • Longer Life Expectancy Bolsters Market Growth
    • Table 10: Life Expectancy for Select Countries in Number of Years (2015E) (includes corresponding Graph/Chart)
    • Table 11: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050 (includes corresponding Graph/Chart)
  • Rising Disposable Incomes Propel Market Growth
    • Table 12: Annual Disposable Incomes in US$ Thousand for Select Countries (2012) (includes corresponding Graph/Chart)
    • Table 13: Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P (includes corresponding Graph/Chart)
  • Improving Healthcare Expenditure to Foster Growth
    • Table 14: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 15: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart)

5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET

  • RNS Assists Medical Practitioners in Treating Critical Neurological Ailments
  • Investigational DBS Device Inches towards Closed-Loop Functionality
  • Closed-Loop Stimulation - A Potential Solution for Gait Disturbances in DBS Treated PD Patients
  • Vagus Nerve Stimulator Offers Safe and Reliable Epilepsy Treatment for Patients
  • AspireSR Neurostimulator Mitigates Requirement of Brain Surgery
  • AspireSR Neurostimulator Gains Momentum
  • Medtronic's SCS System Brings Paradigm Shift in Neurostimulators Market
  • Equilia System Provides Cost-Effective Treatment for Cardiovascular Patients
  • Portable Neuromodulation Device to Improve Walking in Multiple Sclerosis Patients
  • Emerging PNS Technologies to Drive Neuromodulation Device Market
  • Mainstay ReActive8
  • SMARTPATCH PNS System from SPR Therapeutics
  • Neuros Medical's Electrical Nerve Block Technology
  • I-Patch from Direct Spinal Therapeutics
  • Valtronic and NDI Medical to Develop Miniature Implantable Pulse Generator
  • Neuromodulation Device for Obstructive Sleep Apnea Treatment
  • SetPoint Medical's Vagus Nerve Stimulation Technology
  • Other Potential Applications for PNS Technology

6. SELECT TARGETED INDICATIONS

  • Parkinson's Disease - The Largest Application Market for DBS
  • A Note on Incidence and Prevalence of Parkinson's Disease
    • Table 16: Global Prevalence of Parkinson's Disease (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)
  • Research Suggests Greater Benefits of DBS in Parkinson's
  • Incidence and Prevalence of Essential Tremor
  • DBS in Dystonia
  • Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical Studies and Meta-Analyses
  • Dystonia Patient Selection Criteria for DBS
  • DBS in OCD
  • DBS in Epilepsy Treatment
    • Table 17: Global Prevalence of Epilepsy (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)
  • DBS in Tourette Syndrome - Research Progress So Far
  • Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select Clinical Studies and Meta-Analyses
  • Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment
  • Multiple Possible Targets Deter Progress of DBS in Depression Treatment
  • Overview of Select Studies on DBS in Depression Treatment
  • SCC - A Promising Target for Stimulation in Depression
  • Eating Disorders - A Note on Potential of DBS
  • DBS in Obesity - Animal Models Show Promise
  • Anorexia Treatment - Where Does DBS Stand?
  • DBS in Dementia Treatment - Animal Studies Bode Well for Efficacy in Humans
  • Prospects of DBS in Chronic Pain Management
  • SNS for Incontinence
  • Types of Incontinence and Features/Causes for Incontinence
    • Table 18: Worldwide Prevalence (%) of Urinary Incontinence in Men and Women (includes corresponding Graph/Chart)
    • Table 19: Worldwide Prevalence of Stress UI in Women in the Age Group of 15 to 85+ Years by Select Geographic Region: 2013-2020 (includes corresponding Graph/Chart)
  • Sleep Apnea

7. PRODUCT OVERVIEW

  • Introduction to Neurostimulator
  • A Historical Note
  • Neurostimulation Devices by Product Segment
  • Spinal Cord Stimulation (SCS)
    • SCS - What it Treats...
    • Segmentation by Type of Power Source
    • Implantable Pulse Generator Systems (IPGs)
    • Radio Frequency (RF) Systems
    • Market Assessment for RF Systems
  • Sacral Nerve Stimulation (SNS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Gastric Electric Stimulation (GES)
  • Stimulation Device - How it Works
  • Neurostimulation & its Benefits
  • Prospective Application Areas for Neurostimulators - Select Indications
    • Approved Indications for Spinal Cord Stimulation by Geographic Regions
  • Neurostimulation Devices - Technology & Safety Issues

8. NEUROSTIMULATION DEVICE APPROVALS

  • St. Jude Medical Wins CE Mark Approval for MR- Conditional Rechargeable Spinal Cord Stimulator
  • St. Jude Medical Nabs CE Mark for Infinity Deep Brain Stimulation System and Directional DBS Lead
  • EndoStim Receives CE Mark Approval for EndoStim II
  • St. Jude Medical Wins Health Canada Approval for Prodigy Spinal Cord Stimulator
  • St. Jude Medical Bags FDA Approval for Brio Neurostimulation System for Parkinson's Disease
  • Medtronic Receives European Approval of Full-Body MR Conditional Deep Brain Stimulation Systems
  • AdvaStim Gets Neurostimulation Patent
  • St. Jude Bags EU Regulatory Approval for Prodigy Neurostimulator with Burst Technology
  • St. Jude Medical Secures FDA Approval for Protege(tm) IPG

9. PRODUCT INNOVATIONS/INTRODUCTIONS

  • NeuroMetrix Introduces Quell(tm) Wearable Pain Relief Technology
  • NeuroMetrix Unveils SENSUS Pain Management System
  • Medtronic Rolls Out Neurostimulation Systems for Chronic Pain

10. RECENT INDUSTRY ACTIVITY

  • St. Jude Medical Snaps Up Spinal Modulation
  • Allergan Acquires Oculeve
  • Medtronic Takes Over Advanced Uro-Solutions
  • Sorin and Cyberonics Announces Merger
  • Greatbatch Spins Off Algostim
  • Medtronic Takes Over Sapiens Steering Brain Stimulation
  • Kelyniam Global Snaps Up MED-ALLY
  • AdvaStim Forays into Neuromodulation Device Market
  • Aurora BioScience Inks Distribution Agreement with Synapse Biomedical
  • Sorin Group Acquires Neurotech
  • St Jude Medical and Spinal Modulation Ink Distribution Agreements
  • Boston Scientific Commences Trial for Neurostimulation Evaluation in Chronic Migraine Treatment
  • Spinal Modulation Starts Trial for Neurostim Device

11. FOCUS ON SELECT PLAYERS

  • Aleva Neurotherapeutics SA (Switzerland)
  • BioControl Medical (Israel)
  • Bioness Inc. (USA)
  • Boston Scientific Corp. (USA)
  • EnteroMedics Inc. (USA)
  • LivaNova PLC (UK)
  • Medtronic, Inc. (USA)
  • NeuroPace, Inc. (USA)
  • NeuroSigma, Inc. (USA)
  • Nevro Corp. (USA)
  • SPR Therapeutics, LLC (US)
  • St. Jude Medical, Inc. (USA)
  • Synapse Biomedical, Inc. (USA)

12. GLOBAL MARKET PERSPECTIVE

    • Table 20: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 22: World 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 29: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: World Historic Review for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 31: World 14-Year Perspective for Sacral Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 32: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 33: World Historic Review for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 34: World 14-Year Perspective for Vagus Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 35: World Recent Past, Current & Future Analysis for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: World Historic Review for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 37: World 14-Year Perspective for Gastric Electric Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Overview
      • Product Segments Ranked by Growth
    • Table 38: Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Revenue Growth (includes corresponding Graph/Chart)
    • Table 39: Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Unit Sales Growth (includes corresponding Graph/Chart)
      • Neurostimulation Indications and Use of Related Devices/Techniques in the US
      • Potential Growth for Neurostimulation Systems in the US
      • Spinal Cord Stimulation Products Market
      • Sacral Nerve Stimulation Products Market
      • Deep Brain Stimulation Products Market
    • Aging Baby Boomers Benefit Market Prospects in the US
    • Table 40: North American Elderly Population by Age Group: 1975, 2000, 2025P, and 2050P (includes corresponding Graph/Chart)
    • Shift Away from Orthopaedic and Cardiovascular Device Markets
    • Trends in the Embolotherapy Market
    • Neurovascular Stents Market Attracting Cardiovascular Companies
    • Migraine Devices - New Frontiers for Neurostimulation
    • Competitive Landscape
    • Neurostimulation Device Approvals
    • Product Innovations/Introductions
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 41: US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 43: US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 44: US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Neurostimulation Device Approval
  • B. Market Analytics
    • Table 47: Canadian Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: Canadian Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: Canadian 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 50: Japanese Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 51: Japanese Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 52: Japanese 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Increasing Incidence of Neurological Diseases Spur Market Growth
    • Rising Life Expectancy and the Risk of Injury to Drive Demand across Europe
    • Table 53: Life Expectancy at 65 Years for Select Countries in Europe: 2012 (includes corresponding Graph/Chart)
    • Table 54: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)
    • Neurostimulation Device Approvals
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 55: European Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 56: European Historic Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 57: European 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 58: European Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 59: European Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 60: European 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Neurostimulation Devices Market Exhibits Substantial Growth
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 61: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 62: Asia-Pacific Historic Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 63: Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 65: Asia-Pacific Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 66: Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 67: Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 68: Latin American Historic Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 69: Latin American 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 70: Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 71: Latin American Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 72: Latin American 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Business-Friendly Government Policies Fuels Market Growth
    • BioControl Medical - A Major Israeli Player
  • B. Market Analytics
    • Table 73: Rest of World Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Rest of World Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 75: Rest of World 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top